IVAX to Present at the UBS Warburg Conference

     
BW20030602002180  20030603T060032Z UTC


( BW)(IVAX-CORPORATION)(IVX) IVAX to Present at the UBS Warburg
Conference

    Business Editors
    UK REGULATORY NEWS

    LONDON & MIAMI--(BUSINESS WIRE)--June 3, 2003--

IVAX Corporation (AMEX: IVX; LSE: IVX.L) is scheduled to make a
presentation on Wednesday, June 4, 2003, at 11:30 a.m. Eastern Time at
the UBS Warburg Global Specialty Pharmaceuticals Conference being held
at the Grand Hyatt New York in New York City, New York.

IVAX' presentation will be webcast and accessible to the public online
by going to our website at www.ivax.com and clicking on the link.
Through this link, visitors will be able to access the company's
presentation made by Neil Flanzraich, vice chairman and president of
IVAX Corporation. Replays will be available for 14 days after the
presentation at the same web site address.

IVAX Corporation, headquartered in Miami, Florida, discovers,
develops, manufactures, and markets branded and brand equivalent
(generic) pharmaceuticals and veterinary products in the U.S. and
internationally.

Copies of this and other news releases may be obtained free of charge
from IVAX' web site at www.ivax.com.


   Short Name: IVAX Corporation
   Category Code: MSC
   Sequence Number: 00005396
   Time of Receipt (offset from UTC): 20030602T214414+0100

    --30--CK/ny*

    CONTACT: IVAX Corporation
             Director/Corporate Governance
             Jim Whitlow, 305/575-6043


    KEYWORD: FLORIDA UNITED KINGDOM INTERNATIONAL EUROPE
    INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL 
    SOURCE: IVAX Corporation

Today's News On The Net - Business Wire's full file on the Internet
                          with Hyperlinks to your home page.
                          URL: http://www.businesswire.com